Nucleai, GoPath Diagnostics Partner to Power AI-Powered Digital Pathology
Nucleai and GoPath Diagnostics announced a strategic collaboration to revolutionize clinical trials, diagnostics, and research in oncology...
Stay updated with breaking news from Path Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nucleai and GoPath Diagnostics announced a strategic collaboration to revolutionize clinical trials, diagnostics, and research in oncology...
Chicago, Illinois (PRWEB) April 06, 2023 -- GoPath Diagnostics, a leading innovative molecular diagnostic company, is proud to announce that they have
Share this article Share this article ResearchAndMarkets.com's offering. The global genetic counseling market was valued at $972.2 million in 2019 and is anticipated to grow over $4,079.3 million by 2030. The pharmacogenomic genetic counseling segment is expected to witness a robust CAGR of 17.39% during the forecast period, 2020-2030. GeneDX and InformedDNA are currently the largest shareholders in the global genetic counseling market. This market dominance is attributed to the company's presence within the market through its expansive service portfolio, led by dedicated genetic counselor...